Guggenheim raised the firm’s price target on Legence (LGN) to $74 from $68 and keeps a Buy rating on the shares following release on Friday of the company’s Q4 results and 2026 outlook.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
- Legence price target raised to $63 from $52 at Goldman Sachs
- Legence Corp. Delivers Record Results, Lifts 2026 Outlook
- Tigress Financial sees AI momentum powering gowth for Legence
- Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
- Morning Movers: AstraZeneca jumps following tozorakimab trial results